HomeAboutFaculty DirectoryMEDINA Marie-jo

MEDINA Marie-jo

Pandemics are low-probability, high-impact events. They do not occur often but, when they do, the risk to global health, life, and property is tremendous. We tend to misrepresent the importance of pandemics by either exaggerating or disregarding them. Exaggeration breeds fear and disregard, complacency either of which makes us vulnerable to a disaster. We do not need to be afraid or to remain complacent, but we do need to be prepared.

Pandemic preparedness is made challenging by our lack of understanding of microorganisms, human immunity, the environment, and how their interaction with each other brings about a disaster. To be consistently prepared, we need sustained investments in high-quality, translational research with a One Health perspective, and unwavering commitment to the Global Health Security Agenda.


  • NUS Saw Swee Hock School of Public Health

Research Areas:

  • Common Cold Viruses: Human-to-Human Transmission, Genetic Evolution
  • Pandemic Influenza: Preparedness and Response, Vaccine Phase I - III Trials
  • Seasonal Influenza: Vaccine Selection, Antiviral Resistance
  • Streptococcus Pneumoniae: Vaccine Determination, Antimicrobial Resistance

Academic/Professional Qualifications:

  • BS, Biology & Chemistry – Bridgewater State University, Bridgewater, MA (USA)
  • MS, Biomedical Science – Northeastern University, Boston, MA (USA)
  • MSc, Emergency Planning and Risk Management – University of Leicester, Leicester (UK)
  • PhD, Infection, Immunity & Inflammation – University of Leicester, Leicester (UK)

Career History:

  • Duke-NUS, Singapore (2016) – Research Associate, Laboratory of Virus Evolution
  • University of Leicester, Leicester, UK (2006) – Research Associate, Infectious Diseases and Vaccine Evaluation Centre
  • Centers for Disease Control and Prevention, Atlanta, USA (2003) – Research Fellow, Influenza Division
  • Centers for Disease Control and Prevention, Atlanta, USA (2002) – Research Training Fellow, Streptococcal Genetics

Selected Publications:

  • Medina, M. (2016) 'Pandemic influenza planning for the mental health security of survivors of mass deaths', in A.J. Masys (editor) 'Exploring the security landscape: Non-traditional security challenges', Switzerland: Springer International Publishing: 79-100.
  • Nicholson KG, Abrams KR, Batham S, Medina M, Warren FC, Barer M, Bermingham A, Clark TW, Latimer N, Fraser M, Perera M, Rajakumar K, and Zambon M. 2014. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year olds. Health Technol Assess 18(36): 1-274.
  • Chor JS, Pada SK, Stephenson I, Goggins WB, Tambyah PA, Clarke TW, Medina M, Lee N, Leung TF, Ngai KL, Law SK, Rainer TH, Griffiths S, Chan PK. 2011. Seasonal influenza vaccination predicts pandemic H1N1 vaccination uptake among healthcare workers in three countries. Vaccine 29(43): 7364-9.
  • Nicholson KG, Abrams KR, Batham S, Clark TW, Hoschler K, Lim WS, Medina M, Nguyen-Van-Tam JS, Read RC, Warren FC, Zambon M. 2011. Immunogenicity and safety of a two-dose schedule of whole-virion and ASO3(A)-adjuvanted 2009 influenza A(H1N1) vaccines: a randomized, multicentre, age-stratified head-to-head trial. Lancet Infectious Diseases 11(2):91-101
  • Beall B, McEllistrem MC, Gertz RE Jr, Wedel S, Boxrud DJ, Gonzalez AL, Medina MJ, Pai R, Thompson TA, Harrison LH, McGee L, Whitney CG; Active Bacterial Core Surveillance Team. 2006. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J Clin Microbiol 44(3):999-1017.
  • Bright, R.A., M. Medina, X. Xu, G. Perez-Oronoz, T.R. Wallis, L. Povinelli, N.J. Cox, and A.I. Klimov. 2005. Incidence of adamantane resistance among influenza A(H3N2) viruses isolated worldwide from 1994 to 2004: A cause for concern. Lancet 366(9492):1175-81.
  • The World Health Organization Global Influenza Program Surveillance Network. 2005. Evolution of H5N1 avian influenza viruses in Asia. Emerging Infectious Diseases 11(10):1515-1521.
  • Crawford, P.C., E.J. Dubovi, W.L. Castleman, I. Stephenson, E.P.J. Gibbs, L. Chen, C. Smith, R.C. Hill, P. Ferro, R.A. Bright, M. Medina, C.M. Johnson, C.W. Olsen, N.J. Cox, A.I. Klimov, J.M. Katz, and R.O. Donis. 2005. Transmission of equine influenza virus to dogs. Science 310(5747):482-5.
  • Medina, M., C.M. Green, R.E. Gertz, R.R. Facklam, G. Jagero, M. Hamel, Y. Shi, L. Slutsker, D.R. Feikin, and B. Beall. 2005. Novel antibiotic-resistant pneumococcal strains recovered from the upper respiratory tracts of HIV-infected adults and their children in Kisumu, Kenya. Microbial Drug Resistance 11(1): 9-17.
Postdoctoral Fellow
Email ephmjm@nus.edu.sg


Saw Swee Hock School of Public Health
Tahir Foundation Building
National University of Singapore
12 Science Drive 2
Singapore 117549
For all visitors, kindly proceed to Level 10 Reception Area at MD1
Telephone: (65) 6516 4988
Fascimile: (65) 6779 1489

Connect With Us:     

© National University of Singapore. All Rights Reserved.
Legal   Branding guidelines